{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+Vaccine+Polyvalent-Pneumovax+23", "query": { "intervention": "Pneumococcal Vaccine Polyvalent-Pneumovax 23" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 46, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+Vaccine+Polyvalent-Pneumovax+23&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T00:15:19.538Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00000829", "title": "A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections", "Pneumococcal Infections" ], "interventions": [ { "name": "Pneumococcal Vaccine, Polyvalent (23-valent)", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine, Heptavalent", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "6 Months", "sex": "ALL", "summary": "2 Months to 6 Months" }, "enrollment_count": 60, "start_date": null, "completion_date": "1999-10", "has_results": false, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 31, "location_summary": "Los Angeles, California • Oakland, California • San Diego, California + 21 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000829" }, { "nct_id": "NCT04583618", "title": "Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine - formulation 2-SP0202-VI", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine - formulation 3-SP0202-VII", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13 - valent conjugate vaccine-Prevnar 13", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Vaccine Polyvalent-Pneumovax 23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "50 Years to 84 Years" }, "enrollment_count": 750, "start_date": "2020-10-08", "completion_date": "2022-01-20", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 17, "location_summary": "Anaheim, California • Rolling Hills Estates, California • Wheat Ridge, Colorado + 14 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04583618" }, { "nct_id": "NCT02079701", "title": "Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pneumonia", "Acute Respiratory Disease" ], "interventions": [ { "name": "23-valent pneumococcal vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Naval Health Research Center", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 152723, "start_date": "2000-10", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2014-03-06", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 5, "location_summary": "San Diego, California • Great Lakes, Illinois • Fort Leonard Wood, Missouri + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Great Lakes", "state": "Illinois" }, { "city": "Fort Leonard Wood", "state": "Missouri" }, { "city": "Fort Jackson", "state": "South Carolina" }, { "city": "Parris Island", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02079701" }, { "nct_id": "NCT00013871", "title": "Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Hepatitis B", "Measles", "Pneumococcal Infections", "Pertussis" ], "interventions": [ { "name": "Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed", "type": "BIOLOGICAL" }, { "name": "Measles-Mumps-Rubella Vaccine (Live)", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Vaccine, Polyvalent (23-valent)", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine, Heptavalent", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine (Recombinant)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 300, "start_date": null, "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Long Beach, California • Los Angeles, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00013871" }, { "nct_id": "NCT00034086", "title": "Study of Anti-HIV Therapy Intensification", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Lopinavir/Ritonavir", "type": "DRUG" }, { "name": "Lamivudine/Zidovudine", "type": "DRUG" }, { "name": "Tenofovir disoproxil fumarate", "type": "DRUG" }, { "name": "Pneumococcal Vaccine, Polyvalent (23-valent)", "type": "BIOLOGICAL" }, { "name": "Lamivudine", "type": "DRUG" }, { "name": "Stavudine", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" }, { "name": "Didanosine", "type": "DRUG" }, { "name": "Lyme Disease Vaccine Recombinant OspA", "type": "BIOLOGICAL" }, { "name": "Haemophilus B Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 22, "start_date": null, "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2012-05-18", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 3, "location_summary": "Aurora, Colorado • Chicago, Illinois • Cleveland, Ohio", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00034086" }, { "nct_id": "NCT00457977", "title": "Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Pneumovax (PPSV23)", "type": "BIOLOGICAL" }, { "name": "Prevnar (PCV7)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 181, "start_date": "2007-03", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2015-05-12", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00457977" }, { "nct_id": "NCT03039491", "title": "Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "HIV Lipodystrophy", "Aging" ], "interventions": [ { "name": "Pneumococcal polysaccharide vaccine 23 valent", "type": "BIOLOGICAL" }, { "name": "13 valent conjugated pneumococcal vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 160, "start_date": "2015-09-01", "completion_date": "2020-03-30", "has_results": false, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03039491" }, { "nct_id": "NCT00829595", "title": "Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Bowel Disease", "Crohn Disease", "Ulcerative Colitis" ], "interventions": [ { "name": "23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2005-05", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2009-01-27", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00829595" }, { "nct_id": "NCT03480802", "title": "A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "PNEUMOVAX™23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 302, "start_date": "2018-07-06", "completion_date": "2020-01-17", "has_results": true, "last_update_posted_date": "2022-05-05", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 4, "location_summary": "Orlando, Florida • West Palm Beach, Florida • Houston, Texas", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03480802" }, { "nct_id": "NCT05417165", "title": "Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma" ], "interventions": [ { "name": "Pneumococcal 20-valent Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Polyvalent Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seema Bhat", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2023-09-29", "completion_date": "2026-10-31", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-10-04T00:15:19.538Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05417165" } ] }